By Professor Bruce Neal

Journal articles

Jardine MJ; Zhou Z; Mahaffey KW; Oshima M; Agarwal R; Bakris G; Bajaj HS; Bull S; Cannon CP; Charytan DM; De Zeeuw D; Di Tanna GL; Greene T; Heerspink HJL; Levin A; Neal B; Pollock C; Qiu R; Sun T; Wheeler DC; Zhang H; Zinman B; Rosenthal N; Perkovic V, 2020, 'Renal, cardiovascular, and safety outcomes of canagliflozin by baseline kidney function: A secondary analysis of the CREDENCE randomized trial', Journal of the American Society of Nephrology, 31, pp. 1128 - 1139, http://dx.doi.org/10.1681/ASN.2019111168

Heerspink HJL; Li JW; Neal B; de Zeeuw D, 2020, 'Reply: Mediators of the Effects of Canagliflozin on Heart Failure: Central Role of the Cardiorenal Axis', JACC: Heart Failure, 8, pp. 427, http://dx.doi.org/10.1016/j.jchf.2020.02.005

Grimes CA; Khokhar D; Bolton KA; Trieu K; Potter J; Davidson C; Dunford EK; Jan S; Woodward M; Bolam B; Neal B; Nowson C; Webster J, 2020, 'Salt-related knowledge, attitudes and behaviors (KABS) among victorian adults following 22-months of a consumer awareness campaign', Nutrients, 12, pp. 1216, http://dx.doi.org/10.3390/nu12051216

Clemens KK; Woodward M; Neal B; Zinman B, 2020, 'Sex disparities in cardiovascular outcome trials of populations with diabetes: A Systematic Review and Meta-analysis', Diabetes Care, 43, pp. 1157 - 1163, http://dx.doi.org/10.2337/dc19-2257

Marklund M; Singh G; Greer R; Cudhea F; Matsushita K; Micha R; Brady T; Zhao D; Huang L; Tian M; Cobb L; Neal B; Appel LJ; Mozaffarian D; Wu JHY, 2020, 'Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: Modelling study', The BMJ, 369, pp. m824, http://dx.doi.org/10.1136/bmj.m824

Neal B; Arnott C, 2020, 'A Novel Cardioprotective Therapy That Also Improves Glycemia', JAMA - Journal of the American Medical Association, 323, pp. 1349 - 1350, http://dx.doi.org/10.1001/jama.2020.1905

Lappi VM; Mottas A; Sundström J; Neal B; Löf M; Rådholm K, 2020, 'A comparison of the nutritional qualities of supermarket’s own and regular brands of bread in sweden', Nutrients, 12, pp. 1162, http://dx.doi.org/10.3390/nu12041162

Ndanuko RN; Dunford EK; Wu JHY; Raubenheimer D; Neal BC, 2020, 'Changes in sodium levels of processed foods among the International Food and Beverage Association member companies in Australia: 2013–2017', Journal of Food Composition and Analysis, 87, pp. 103405, http://dx.doi.org/10.1016/j.jfca.2019.103405

Ohkuma T; Van Gaal L; Shaw W; Mahaffey KW; de Zeeuw D; Matthews DR; Perkovic V; Neal B, 2020, 'Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program', Diabetes, Obesity and Metabolism, 22, pp. 530 - 539, http://dx.doi.org/10.1111/dom.13920

Huang L; Tian M; Yu J; Li Q; Liu Y; Yin X; Wu JH; Marklund M; Wu Y; Li N; Elliott P; Yan LL; Labarthe DR; Hao Z; Shi J; Feng X; Zhang J; Zhang Y; Zhang R; Zhou B; Li Z; Sun J; Zhao Y; Yu Y; Neal B, 2020, 'Interim effects of salt substitution on urinary electrolytes and blood pressure in the China Salt Substitute and Stroke Study (SSaSS)', American Heart Journal, 221, pp. 136 - 145, http://dx.doi.org/10.1016/j.ahj.2019.12.020

Bikbov B; Purcell C; Levey AS; Smith M; Abdoli A; Abebe M; Adebayo OM; Afarideh M; Agarwal SK; Agudelo-Botero M; Ahmadian E; Al-Aly Z; Alipour V; Almasi-Hashiani A; Al-Raddadi RM; Alvis-Guzman N; Amini S; Andrei T; Andrei CL; Andualem Z; Anjomshoa M; Arabloo J; Ashagre AF; Asmelash D; Ataro Z; Atout MMDW; Ayanore MA; Badawi A; Bakhtiari A; Ballew SH; Balouchi A; Banach M; Barquera S; Basu S; Bayih MT; Bedi N; Bello AK; Bensenor IM; Bijani A; Boloor A; Borzì AM; Cámera LA; Carrero JJ; Carvalho F; Castro F; Catalá-López F; Chang AR; Chin KL; Chung SC; Cirillo M; Cousin E; Dandona L; Dandona R; Daryani A; Das Gupta R; Demeke FM; Demoz GT; Desta DM; Do HP; Duncan BB; Eftekhari A; Esteghamati A; Fatima SS; Fernandes JC; Fernandes E; Fischer F; Freitas M; Gad MM; Gebremeskel GG; Gebresillassie BM; Geta B; Ghafourifard M; Ghajar A; Ghith N; Gill PS; Ginawi IA; Gupta R; Hafezi-Nejad N; Haj-Mirzaian A; Haj-Mirzaian A; Hariyani N; Hasan M; Hasankhani M; Hasanzadeh A; Hassen HY; Hay SI; Heidari B; Herteliu C; Hoang CL; Hosseini M; Hostiuc M; Irvani SSN; Islam SMS; Jafari Balalami N; James SL; Jassal SK; Jha V; Jonas JB; Joukar F; Jozwiak JJ; Neal B; Schutte A, 2020, 'Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017', The Lancet, 395, pp. 709 - 733, http://dx.doi.org/10.1016/S0140-6736(20)30045-3

Huang L; Trieu K; Yoshimura S; Neal B; Woodward M; Campbell NRC; Li Q; Lackland DT; Leung AA; Anderson CAM; Macgregor GA; He FJ, 2020, 'Effect of dose and duration of reduction in dietary sodium on blood pressure levels: Systematic review and meta-analysis of randomised trials', The BMJ, 368, pp. m315, http://dx.doi.org/10.1136/bmj.m315

Jafar TH; Gandhi M; de Silva HA; Jehan I; Naheed A; Finkelstein EA; Turner EL; Morisky D; Kasturiratne A; Khan AH; Clemens JD; Ebrahim S; Assam PN; Feng L; Neal B, 2020, 'A Community-Based Intervention for Managing Hypertension in Rural South Asia.', New England Journal of Medicine, 382, pp. 717 - 726, http://dx.doi.org/10.1056/nejmoa1911965

Cannon CP; Perkovic V; Agarwal R; Baldassarre J; Bakris G; Charytan DM; De Zeeuw D; Edwards R; Greene T; Heerspink HJL; Jardine MJ; Levin A; Li JW; Neal B; Pollock C; Wheeler DC; Zhang H; Zinman B; Mahaffey KW, 2020, 'Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial', Circulation, 141, pp. 407 - 410, http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044359

Arnott C; Li Q; Kang A; Neuen BL; Bompoint S; Lam CSP; Rodgers A; Mahaffey KW; Cannon CP; Perkovic V; Jardine MJ; Neal B, 2020, 'Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis', Journal of the American Heart Association, 9, pp. e014908, http://dx.doi.org/10.1161/JAHA.119.014908

Rådholm K; Zhou Z; Clemens K; Neal B; Woodward M, 2020, 'Effects of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes in women versus men', Diabetes, Obesity and Metabolism, 22, pp. 263 - 266, http://dx.doi.org/10.1111/dom.13876

Li JW; Woodward M; Perkovic V; Figtree GA; Heerspink HJL; Mahaffey KW; de Zeeuw D; Vercruysse F; Shaw W; Matthews DR; Neal B, 2020, 'Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes', JACC: Heart Failure, 8, pp. 57 - 66, http://dx.doi.org/10.1016/j.jchf.2019.08.004

Bolton KA; Webster J; Dunford EK; Jan S; Woodward M; Bolam B; Neal B; Trieu K; Reimers J; Armstrong S; Nowson C; Grimes C, 2020, 'Sources of dietary sodium and implications for a state-wide salt reduction program in Victoria, Australia', British Journal of Nutrition, 123, pp. 1165 - 1175, http://dx.doi.org/10.1017/S000711452000032X

Heerspink HJL; Oshima M; Jardine MJ; Agarwal R; Bakris GL; Cannon CP; Charytan DM; de Zeeuw D; Edwards R; Greene T; Levin A; Mahaffey KW; Neal B; Pollock CA; Rosenthal N; Wheeler DC; Zhang H; Zinman B; Perkovic V, 2020, 'Acute Declines in eGFR During Treatment with Canagliflozin (CANA) and Its Implications for Clinical Practice: Insights from CREDENCE', Journal of the American Society of Nephrology, 31, pp. 342 - 343, http://dx.doi.org/10.1681/asn.20203110s1342b

Sen T; Li J; Neuen BL; Parikh CR; Coca SG; Neal B; Perkovic V; de Zeeuw D; Mahaffey KW; Hansen MK; Heerspink HJL, 2020, 'Associations Between TNFR-1, TNFR-2, and KIM-1 with Kidney and Cardiovascular Outcomes: Results from the CANVAS Trial', Journal of the American Society of Nephrology, 31, pp. 338 - 338, http://dx.doi.org/10.1681/asn.20203110s1338c

Neuen BL; Yu J; Li Q; Perkovic V; Arnott CG; Neal B; Heerspink HJL; Agarwal R; Bakris GL; Cannon CP; de Zeeuw D; Charytan DM; Levin A; Di Tanna GL; Matthews DR; Pollock CA; Wheeler DC; Mahaffey KW; Jardine MJ, 2020, 'Canagliflozin Across the Spectrum of Kidney Function and Albuminuria: Integrated Data from CANVAS and CREDENCE', Journal of the American Society of Nephrology, 31, pp. b6 - b6, http://dx.doi.org/10.1681/asn.20203110s1b6a

Kang A; Neuen BL; Heerspink HJL; Di Tanna GL; Neal B; Zhang H; Hockham C; Agarwal R; Bakris GL; Charytan DM; de Zeeuw D; Greene T; Levin A; Pollock CA; Wheeler DC; Zinman B; Mahaffey KW; Perkovic V; Jardine MJ, 2020, 'Canagliflozin and Risk of Genital Infections and Urinary Tract Infections in People with Diabetes Mellitus and Kidney Disease in the CREDENCE Trial', Journal of the American Society of Nephrology, 31, pp. 343 - 343, http://dx.doi.org/10.1681/asn.20203110s1343c

Kang A; Smyth B; Neuen BL; Heerspink HJL; Di Tanna GL; Neal B; Zhang H; Hockham C; Agarwal R; Bakris GL; Charytan DM; de Zeeuw D; Greene T; Levin A; Pollock CA; Wheeler DC; Zinman B; Mahaffey KW; Perkovic V; Jardine MJ, 2020, 'Canagliflozin and Risk of Skin and Soft Tissue Infections in People with Diabetes Mellitus and Kidney Disease in the CREDENCE Trial', Journal of the American Society of Nephrology, 31, pp. 344 - 344, http://dx.doi.org/10.1681/asn.20203110s1344a

Rasmussen DGK; Jatkoe T; Sparding N; Mϕller AL; Karsdal MA; Rosenthal N; Gutstein DE; Neal B; Perkovic V; Mahaffey KW; Genovese F; Hansen MK, 2020, 'Canagliflozin Treatment Reduces Formation and Increases Degradation of Collagen Type III in the Canagliflozin Cardiovascular Assessment Study (CANVAS)', Journal of the American Society of Nephrology, 31, pp. 343 - 343, http://dx.doi.org/10.1681/asn.20203110s1343b

Levin A; Neuen BL; Mahaffey KW; Cannon CP; Jardine MJ; Heerspink HJL; Neal B; Arnott CG; Zhou Z; Charytan DM; Agarwal R; Bakris GL; de Zeeuw D; Greene T; Wheeler DC; Rosenthal N; Zhang H; Zinman B; Perkovic V; Pollock CA, 2020, 'Effects of Canagliflozin on Cardiovascular, Renal, and Safety Outcomes by Baseline Loop Diuretic Use: Data from the CREDENCE Trial', Journal of the American Society of Nephrology, 31, pp. 342 - 342, http://dx.doi.org/10.1681/asn.20203110s1342a

Young TK; Li J; Kang A; Heerspink HJL; Hockham C; Arnott CG; Neuen BL; Zoungas S; Mahaffey KW; Perkovic V; de Zeeuw D; Fulcher G; Neal B; Jardine MJ, 2020, 'Effects of Canagliflozin on Major Adverse Cardiovascular Events in Patients with Different Baseline Levels of Type 2 Diabetes Disease Severity: Results from the CANVAS Program', Journal of the American Society of Nephrology, 31, pp. 344 - 344, http://dx.doi.org/10.1681/asn.20203110s1344c

Rådholm K; Mottas A; Lappi V-M; Sundström J; Neal B; Mhurchu CN; Löf M, 2020, 'Measuring the healthiness of child-targeted cereals: a study of the FoodSwitch platform in Sweden', Journal of Medical Internet Research, http://dx.doi.org/10.2196/preprints.17780

Arnott C; Li J-W; Cannon CP; Neuen B; Heerspink HL; Neal B; Charytan DM; Agarwal R; Bakris GL; De Zeeuw D; Greene T; Levin A; Pollock C; Chang T; Rosenthal N; Zhang H; Zinman B; Perkovic V; Jardine M; Mahaffey K, 2020, 'THE EFFECTS OF CANAGLIFLOZIN ON HEART FAILURE AND CARDIOVASCULAR DEATH BY BASELINE PARTICIPANT CHARACTERISTICS: ANALYSIS OF THE CREDENCE TRIAL', Journal of the American College of Cardiology, 75, pp. 674, http://dx.doi.org/10.1016/s0735-1097(20)31301-2

Sen T; Li J; Neuen BL; Neal B; Parikh CR; Coca SG; Perkovic V; de Zeeuw D; Mahaffey KW; Hansen MK; Heerspink HJL, 2020, 'The SGLT2 Inhibitor Canagliflozin Reduces the Plasma Markers TNFR-1, TNFR-2, and KIM-1 in the CANVAS Trial', Journal of the American Society of Nephrology, 31, pp. 343 - 343, http://dx.doi.org/10.1681/asn.20203110s1343a

Jones A; Neal B; Reeve B; Ni Mhurchu C; Thow AM, 2019, 'Front-of-pack nutrition labelling to promote healthier diets: Current practice and opportunities to strengthen regulation worldwide', BMJ Global Health, 4, pp. e001882, http://dx.doi.org/10.1136/bmjgh-2019-001882

Li JW; Badve SV; Zhou Z; Rodgers A; Day R; Oh R; Lee M; Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Matthews DR; Neal B, 2019, 'The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program', The Lancet Rheumatology, 1, pp. e220 - e228, http://dx.doi.org/10.1016/S2665-9913(19)30078-5

Arnott C; Neal B, 2019, 'Do GLP-1 receptor agonists care if you have heart failure?', Circulation, 140, pp. 1623 - 1625, http://dx.doi.org/10.1161/CIRCULATIONAHA.119.043303

Dunford EK; Ni Mhurchu C; Huang L; Vandevijvere S; Swinburn B; Pravst I; Tolentino-Mayo L; Reyes M; L'Abbé M; Neal BC, 2019, 'A comparison of the healthiness of packaged foods and beverages from 12 countries using the Health Star Rating nutrient profiling system, 2013–2018', Obesity Reviews, 20, pp. 107 - 115, http://dx.doi.org/10.1111/obr.12879

Carcel C; Neal B; Oparil S; Rogers K; Narkiewicz K; Wang JG; Schiffrin EL; Poulter N; Azizi M; Chalmers J, 2019, 'Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: The Survey of PatIents with treatment ResIstant hyperTension study', Journal of Hypertension, 37, pp. 2216 - 2224, http://dx.doi.org/10.1097/HJH.0000000000002184

Neuen BL; Young T; Heerspink HJL; Neal B; Perkovic V; Billot L; Mahaffey KW; Charytan DM; Wheeler DC; Arnott C; Bompoint S; Levin A; Jardine MJ, 2019, 'SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis', The Lancet Diabetes and Endocrinology, 7, pp. 845 - 854, http://dx.doi.org/10.1016/S2213-8587(19)30256-6

Zhou Z; Jardine M; Perkovic V; Matthews DR; Mahaffey KW; de Zeeuw D; Fulcher G; Desai M; Oh R; Simpson R; Watts NB; Neal B, 2019, 'Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program', Diabetologia, 62, pp. 1854 - 1867, http://dx.doi.org/10.1007/s00125-019-4955-5

Mahaffey KW; Jardine MJ; Bompoint S; Cannon CP; Neal B; Heerspink HJL; Charytan DM; Edwards R; Agarwal R; Bakris G; Bull S; Capuano G; De Zeeuw D; Greene T; Levin A; Pollock C; Sun T; Wheeler DC; Yavin Y; Zhang H; Zinman B; Rosenthal N; Brenner BM; Perkovic V, 2019, 'Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results from the Randomized CREDENCE Trial', Circulation, 140, pp. 739 - 750, http://dx.doi.org/10.1161/CIRCULATIONAHA.119.042007

Jardine MJ; Li N; Ninomiya T; Feng X; Zhang J; Shi J; Zhang Y; Zhang R; Zhang J; Hao J; Perkovic V; Heerspink HL; Wu Y; Yan LL; Neal B, 2019, 'Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized Trial', Journal of Renal Nutrition, 29, pp. 276 - 284, http://dx.doi.org/10.1053/j.jrn.2018.10.009

Stanaway JD; Afshin A; Gakidou E; Lim SS; Abate D; Abate KH; Abbafati C; Abbasi N; Abbastabar H; Abd-Allah F; Abdela J; Abdelalim A; Abdollahpour I; Abdulkader RS; Abebe M; Abebe Z; Abera SF; Abil OZ; Abraha HN; Abrham AR; Abu-Raddad LJ; Abu-Rmeileh NME; Accrombessi MMK; Acharya D; Acharya P; Adamu AA; Adane AA; Adebayo OM; Adedoyin RA; Adekanmbi V; Ademi Z; Adetokunboh OO; Adib MG; Admasie A; Adsuar JC; Afanvi KA; Afarideh M; Agarwal G; Aggarwal A; Aghayan SA; Agrawal A; Agrawal S; Ahmadi A; Ahmadi M; Ahmadieh H; Ahmed MB; Aichour AN; Aichour I; Aichour MTE; Akbari ME; Akinyemiju T; Akseer N; Al-Aly Z; Al-Eyadhy A; Al-Mekhlafi HM; Alahdab F; Alam K; Alam S; Alam T; Alashi A; Alavian SM; Alene KA; Ali K; Ali SM; Alijanzadeh M; Alizadeh-Navaei R; Aljunid SM; Alkerwi A; Alla F; Alsharif U; Altirkawi K; Alvis-Guzman N; Amare AT; Ammar W; Anber NH; Anderson JA; Andrei CL; Androudi S; Animut MD; Anjomshoa M; Ansha MG; Antó JM; Antonio CAT; Anwari P; Appiah LT; Appiah SCY; Arabloo J; Aremu O; Ärnlöv J; Artaman A; Aryal KK; Asayesh H; Ataro Z; Ausloos M; Avokpaho EFGA; Awasthi A; Ayala Quintanilla BP; Ayer R; Ayuk TB; Azzopardi PS; Leung J; Pesudovs K; Jha V; Neal B; Boufous S; Sachdev P; Degenhardt L; Schutte A; Maulik PK; Resnikoff S, 2019, 'Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))', The Lancet, 393, pp. e44, http://dx.doi.org/10.1016/S0140-6736(19)31429-1

Perkovic V; Jardine MJ; Neal B; Bompoint S; Heerspink HJL; Charytan DM; Edwards R; Agarwal R; Bakris G; Bull S; Cannon CP; Capuano G; Chu PL; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler DC; Yavin Y; Zhang H; Zinman B; Meininger G; Brenner BM; Mahaffey KW; Jha V, 2019, 'Canagliflozin and renal outcomes in type 2 diabetes and nephropathy', New England Journal of Medicine, 380, pp. 2295 - 2306, http://dx.doi.org/10.1056/NEJMoa1811744

LI J; BADVE SV; ZHOU Z; OH R; LEE M; PERKOVIC V; ZEEUW DD; MAHAFFEY KW; FULCHER G; MATTHEWS DR; NEAL B, 2019, '1216-P: The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program', Diabetes, 68, http://dx.doi.org/10.2337/db19-1216-p

MAHAFFEY KW; IANUS J; DAMARAJU CV; NEAL B; ZEEUW DD; FULCHER G; PFEIFER M; MATTHEWS DR, 2019, 'Cause of Hospitalizations in Patients with Type 2 Diabetes Mellitus (T2DM) in the CANVAS Program', Diabetes, 68, http://dx.doi.org/10.2337/db19-1203-p

MATTHEWS DR; WYSHAM CH; DAVIES MJ; SLEE A; ALBA M; LEE M; CAPUANO G; PERKOVIC V; MAHAFFEY KW; NEAL B, 2019, 'Effects of Canagliflozin (CANA) on Initiation of Insulin in CANVAS Program', Diabetes, 68, http://dx.doi.org/10.2337/db19-1206-p

Matthews DR; Li Q; Perkovic V; Mahaffey KW; de Zeeuw D; Fulcher G; Desai M; Hiatt WR; Nehler M; Fabbrini E; Kavalam M; Lee M; Neal B, 2019, 'Effects of canagliflozin on amputation risk in type 2 diabetes: The CANVAS Program', Diabetologia, 62, pp. 926 - 938, http://dx.doi.org/10.1007/s00125-019-4839-8

Oshima M; Ohkuma T; Neal B; Li Q; De Zeeuw D; Mahaffey KW; Fulcher G; Canovatchel W; Matthews DR; Perkovic V; Li Q, 2019, 'FP484DIFFERENT eGFR THRESHOLDS AND THE RENAL EFFECTS OF CANAGLIFLOZIN: DATA FROM THE CANVAS PROGRAM', Nephrology Dialysis Transplantation, 34, pp. gfz106.fp484, http://dx.doi.org/10.1093/ndt/gfz106.fp484

Jin A; Feng X; Zhang R; Wang H; Qiao Q; Feng L; Gao P; Fang H; Neal B; Liu K; Labarthe D; Wu Y, 2019, 'Impact of Salt Substitute and Stepwise Reduction of Salt Supply on Blood Pressure in the Elderly in Nursing Homes (DECIDE-Salt Trial): Protocol and Baseline Characteristics (P13-022-19)', Current Developments in Nutrition, 3, pp. 3013579, http://dx.doi.org/10.1093/cdn/nzz036.p13-022-19

Campbell NRC; He FJ; Tan M; Cappuccio FP; Neal B; Woodward M; Cogswell ME; McLean R; Arcand J; MacGregor G; Whelton P; Jula A; L'Abbe MR; Cobb LK; Lackland DT, 2019, 'The International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) position statement on the use of 24-hour, spot, and short duration (<24 hours) timed urine collections to assess dietary sodium intake', Journal of Clinical Hypertension, 21, pp. 700 - 709, http://dx.doi.org/10.1111/jch.13551

Jones A; Thow AM; Ni Mhurchu C; Sacks G; Neal B, 2019, 'The performance and potential of the Australasian Health Star Rating system: a four-year review using the RE-AIM framework', Australian and New Zealand Journal of Public Health, 43, pp. 355 - 365, http://dx.doi.org/10.1111/1753-6405.12908

Figtree GA; Rådholm K; Barrett TD; Perkovic V; Mahaffey KW; De Zeeuw D; Fulcher G; Matthews DR; Shaw W; Neal B, 2019, 'Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus: Results From the CANVAS Program', Circulation, 139, pp. 2591 - 2593, http://dx.doi.org/10.1161/CIRCULATIONAHA.119.040057

Toyama T; Neuen BL; Jun M; Ohkuma T; Neal B; Jardine MJ; Heerspink HL; Wong MG; Ninomiya T; Wada T; Perkovic V, 2019, 'Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis', Diabetes, Obesity and Metabolism, 21, pp. 1237 - 1250, http://dx.doi.org/10.1111/dom.13648

Back to profile page